Last reviewed · How we verify

Normal saline IV — Competitive Intelligence Brief

Normal saline IV (Normal saline IV) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Crystalloid fluid / Electrolyte replacement solution. Area: General supportive care / Fluid and electrolyte management.

phase 3 Crystalloid fluid / Electrolyte replacement solution General supportive care / Fluid and electrolyte management Small molecule Live · refreshed every 30 min

Target snapshot

Normal saline IV (Normal saline IV) — Dr. Waseem Ullah. Normal saline IV restores fluid and electrolyte balance by delivering a sterile solution of sodium chloride and water directly into the bloodstream.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Normal saline IV TARGET Normal saline IV Dr. Waseem Ullah phase 3 Crystalloid fluid / Electrolyte replacement solution
normal saline - injection normal saline - injection Montefiore Medical Center marketed Crystalloid fluid / Electrolyte replacement solution
Sodium Chloride 0.9% infusion Sodium Chloride 0.9% infusion Hospital Central "Dr. Ignacio Morones Prieto" marketed Crystalloid fluid / Electrolyte replacement solution
saline serum saline serum Hédi Chaker Hospital marketed Crystalloid fluid / Electrolyte replacement solution
Isotonic NaCl Isotonic NaCl Hvidovre University Hospital marketed Crystalloid fluid / Electrolyte replacement solution
Saline solution isotonic 0.9% NaCl Saline solution isotonic 0.9% NaCl Krankenhaus Barmherzige Schwestern Linz marketed Crystalloid fluid / Electrolyte replacement solution
Isotonic sodium chloride 0.9 percent Isotonic sodium chloride 0.9 percent Rigshospitalet, Denmark marketed Crystalloid fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Crystalloid fluid / Electrolyte replacement solution class)

  1. Dr. Waseem Ullah · 1 drug in this class
  2. Fayoum University Hospital · 1 drug in this class
  3. GCP-Service International West GmbH · 1 drug in this class
  4. Hospital Central "Dr. Ignacio Morones Prieto" · 1 drug in this class
  5. Hospital Italiano de Buenos Aires · 1 drug in this class
  6. Hvidovre University Hospital · 1 drug in this class
  7. Hédi Chaker Hospital · 1 drug in this class
  8. Kecioren Education and Training Hospital · 1 drug in this class
  9. Krankenhaus Barmherzige Schwestern Linz · 1 drug in this class
  10. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Normal saline IV — Competitive Intelligence Brief. https://druglandscape.com/ci/normal-saline-iv. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: